Similarity searching and scaffold hopping in synthetically accessible combinatorial chemistry spaces

Journal of Medicinal Chemistry

Volumn 51, Issue 8, 2008, Pages 2468-2480

  Boehm, Markus ^a   Wu, Tong Ying ^b   Haussen, Holger ^c   Lemmen, Christian ^c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

^c BioSolvelT GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCYCLAMIDE; GRANISETRON; SULFONYLUREA DERIVATIVE;

ARTICLE; COMBINATORIAL CHEMISTRY; COMBINATORIAL LIBRARY; COMPUTER AIDED DESIGN; COMPUTER PROGRAM; FOLLOW UP; HIGH THROUGHPUT SCREENING; MATRIX ATTACHMENT REGION; SYNTHESIS; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; COMBINATORIAL CHEMISTRY TECHNIQUES; DRUG DESIGN;

EID: 43049096782     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0707727     Document Type: Article

References (103)

1. Fox, S.; Farr-Jones, S.; Sopchak, L.; Boggs, A.; Comley, J. High-throughput screening: searching for higher productivity. J. Biomol. Screen. 2004, 9, 354-8.
2. Posner, B. A. High-throughput screening-driven lead discovery: meeting the challenges of finding new therapeutics. Curr. Opin. Drug Discov. Devel. 2005, 8, 487-94.
3. Hüser, J.; Lohrmann, E.; Kalihof, B.; Burkhardt, N.; Brüggemeier, U.; Bechem, M. High-throughput Screening for Targeted Lead Discovery. In High-Throughput Screening in Drug Discovery; Hüser. J., Ed.; Wiley-VCH: Weinheim, Germany, 2006; pp 15-36.
4. Lahana, R. How many leads from HTS? Drug Discov. Today 1999, 4, 447-448.
5. Ramesha, C. S. How many leads from HTS? - Comment. Drug Discov. Today 2000, 5, 43-44.
6. Carnero, A. High throughput screening in drug discovery. Clin. Transl. Oncol. 2006, 8, 482-90.
7. Ratner, M. L. File Enrichment: The Way Out of Pharma's Productivity Crisis? In Start-Up; Windhover Information, Inc: Norwalk, CT. 2002.
8. Milne, G. M. Pharmaceutical productivity: the imperative for new paradigms. In Annual Reports in Medicinal Chemistry; Academic Press: New York. 2003; Vol. 38. Chapter 35, pp 383-396.
9. Estep, K. File Enrichment and Hit Follow Up: Evolution and Examples. In ALA LabFusion; Boston, MA. 2004.
10. Smith, G. F. Enabling HTS Hit Follow up via Chcmoinformatics, File-Enrichment and Outsourcing. In High Throughput Medicinal Chemisirv II; MMS Conferencing & Events Ltd., Institute of Physics: London, 2006.
11. Borman, S. Improving Efficiency. To eliminate R&D bottlenecks, drug companies are evaluating all phases of discovery and development and are using novel approaches to speed them up. Chem. Eng. News 2006, 84, 56-78.
12. Dohson, C. M. Chemical space and biology. Nature 2004, 432, 824-8.
13. Lipinski, C.; Hopkins, A. Navigating chemical space for biology and medicine. Nature 2004, 432, 855-61.
14. Koch, M. A.; Sehuffenhauer, A.; Seheek, M.; Wetzel, S.; Casaulta, M.; Odermatt, A.; Ertl, P.; Waldmann, H. Charting biologically relevant chemical space: a structural classification of natural products (SCONP). Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 17272-7.
15. Gorse, A. D. Diversity in medicinal chemistry space. Curr. Top. Med. Chem. 2006, 6, 3-18.
16. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; Feeney, P. J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Delivery Rev. 1997, 23, 3-25.
17. Goodnow, R. A.; Guba, W.; Haap, W. Library design practices for success in lead generation with small molecule libraries. Comb. Chem. High Throughput Screen, 2003, 6, 649-60.
18. Rose, S.; Stevens, A. Computational design strategies for combinatorial libraries. Curr. Opin. Chem. Biol. 2003, 7, 331-9.
19. Young, S. S.; Ge, N. Design of diversity and focused combinatorial libraries in drug discovery. Curr. Opin. Drug Discov. Devel. 2004, 7, 318-24.
20. DeSimone, R. W.; Currie, K. S.; Mitchell, S. A.; Darrow, J. W.; Pippin, D. A. Privileged structures: applications in drug discovery. Comb. Chem. High Throughput Screen. 2004, 7, 473-94.
21. Krier, M.; Bret, G.; Rognan, D. Assessing the scaffold diversity of screening libraries. J. Chem. Inf. Model. 2006, 46, 512-24.
22. Kubinyi, H. Chemogenomics in drug discovery. Enst Sehering Res. Found. Workshop 2006, 1-19.
23. Lengauer, T.; Lemmen, C.; Rarey, M.; Zimmermann, M. Novel technologies for virtual screening. Drug Discov. Today 2004, 9, 27-34.
24. Shoichet, B. K. Virtual screening of chemical libraries. Nature 2004, 432, 862-5.
25. Stahura, F. L.; Bajorath, J. Virtual screening methods that complement HTS. Comb. Chem. High Throughput Screen. 2004, 7, 259-69.
26. Stoermer, M. J. Current status of virtual screening us analysed by target class. Med. Chem. 2006, 2, 89-112.
27. Klebe, G. Virtual ligand screening: strategics, perspectives and limitations. Drug Discov. Today 2006, 11, 580-94.
28. Kubinyi, H. Success Stories of Computer-Aided Design. In Computer Applications in Pharmaceutical Research and Development. Ekins, S., Ed.; John Wiley & Sons: New York. 2006; pp 377-424.
29. Lemmen, C.; Lengauer, T. Computational methods for the structural alignment of molecules. J. Comput. Aided Mol. Des. 2000, 14, 215-32.
30. Bender, A.; Glen, R. C. Molecular similarity: a key technique in molecular informatics. Org. Biomol. Chem. 2004, 2, 3204-18.
31. Willett, P. Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 2006, 11, 1046-53.
32. Downs, G. M.; Willett, P. Similarity Searching in Databases of Chemical Structures. In Reviews in Computational Chemistry; Kenny B. Lipkowitz, D. B. B., Ed.; Wiley-VCH: Hoboken, NJ. 2007; pp 1-66.
33. Eckert, H.; Bajorath, J. Molecular similarity analysis in virtual screening: foundations, limitations and novel approaches. Drug Discov. Today 2007, 12, 225-33.
34. MDL, MDL Information Systems Inc., http://www.ntdli.com/.
35. McGregor, M. J.; Pallai, P. V. Clustering of large databases of compounds: using MDL "Keys" as structural descriptors. J. Chem. Inf. Model. 1997, 37, 443-8.
36. Daylight, Daylight Chemical Information Systems Inc., http://www.daylight.com/.
37. McGregor, M. J.; Muskal, S. M. Pharmacophore fingerprinting. I. Application to QSAR and focused library design. J. Chem. Inf. Model. 1999, 39, 569-74.
38. Godden, J. W.; Xuc, L.; Stahura, F. L.; Bajorath, J. Searching for molecules with similar biological activity: analysis by fingerprint profiling. Pac. Symp. Biocomput. 2000, 566-75.
39. Schneider, G.; Lee, M. L.; Stahl, M.; Schneider, P. De novo design of molecular architectures by evolutionary assembly of drug-derived building blocks. J. Comput. Aided Mol. Des. 2000, 14, 487-94.
40. Langer, T.; Wolber, G. Virtual combinatorial chemistry and in silico screening: Efficient tools for lead structure discovery. Pure Appl. Chem. 2004, 76, 991-996.
41. Cramer, R. D.; Patterson, D. E.; Clark, R. D.; Soltanshahi, F.; Lawless, M. S. Virtual Compound Libraries: A New Approach to Decision Making in Molecular Discovery Research. J. Chem. Inf. Comput. Sci. 1998, 38, 1010-1023.
42. Cramer, R. D.; Poss, M. A.; Hermsmeier, M. A.; Caulfield, T. J.; Kowala, M. C.; Valentine, M. T. Prospective identification of biologically active structures by topomer shape similarity searching. J. Med. Chem. 1999, 42, 3919-33.
43. Andrews, K. M.; Cramer, R. D. Toward general methods of targeted library design: topomer shape similarity searching with diverse structures as queries. J. Med. Chem. 2000, 43, 1723-40.
44. Nikitin, S.; Zaitseva, N.; Demina, O.; Solovieva, V.; Mazin, E.; Mikhalev, S.; Smolov, M.; Rubinov, A.; Vlasov, P.; Lepikhin, D.; Khachko, D.; Fokin, V.; Queen, C.; Zosimov, V. A very large diversity space of synthetically accessible compounds for use with drug design programs. J. Comput. Aided Mol. Des. 2005, 19, 47-63.
45. Barnard, J. M.; Downs, G. M.; von Scholley-Pfab, A.; Brown, R. D. Use of Mnrkush structure analysis techniques for descriptor generation and clustering of large combinatorial libraries. J. Mol. Graph Model. 2000, 18, 452-63.
46. Rarey, M.; Dixon, J. S. Feature trees: a new molecular similarity measure based on tree matching. J. Comput. Aided Mol. Des. 1998, 12, 471-90.
47. Rarey, M.; Stahl, M. Similarity searching in large combinatorial chemistry spaces. J. Comput. Aided Mol. Des. 2001, 15, 497-520.
48. Rarey, M.; Hindle, S.; Maass, P.; Metz, G.; Rummey, C.; Zimmermann, M. Feature Trees: Theory and Applications from Large-scale Virtual Screening to Data Analysis. In Pharmacophores and Pharmacophore Searches. Thierry Lunger, R. D. H., Ed.; Wiley-VCH: Weinheim, Germany, 2006; pp 81-116.
49. Cramer, R. D.; Jilek, R. J.; Guessregen, S.; Clark, S. J.; Wendt, B.; Clark, R. D. "Lead hopping. Validation of topomer similarity as a superior predictor of similar biological activities. J. Med. Chem. 2004, 47, 6777-91.
50. Good, A. C.; Hermsmeicr, M. A.; Hindle, S. A. Measuring CAMD technique performance: a virtual screening case study in the design of validation experiments. J. Comput. Aided Mol. Des. 2004, 18, 529-36.
51. Evers, A.; Hessler, G.; Matter, H.; Klabunde, T. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols. J. Med. Chem. 2005, 48, 5448-65.
52. Hessler, G.; Zimmermann, M.; Matter, H.; Evers, A.; Naumann, T.; Lengauer, T.; Rarey, M. Multiple-Iigand-based virtual screening: methods and applications of the MTrce approach. J. Med. Chem. 2005, 48, 6575-84.
53. Barker, E. J.; Buttar, D.; Cosgrove, D. A.; Gardiner, E. J.; Kitts, P.; Willett, P.; Gillet, V. J. Scaffold hopping using clique detection applied to reduced graphs. J. Chem. Inf. Model. 2006, 46, 503-11.
54. Renner, S.; Schneider, G. Scaffold-hopping potential of ligand-based similarity concepts. Chem. Med. Chem. 2006, 1, 181-5.
55. Stiefl, N.; Zaliani, A. A knowledge-based weighting approach to ligand-based virtual screening. J. Chem. Inf. Model. 2006, 46, 587-96.
56. Zhang, Q.; Muegge, I. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring. J. Med. Chem. 2006, 49, 1536-48.
57. Bergmann, R.; Linusson, A.; Zamora, I. SHOP: Scaffold HOPping by GRID-Based Similarity Searches. J. Med. Chem. 2007.
58. Zhao, H. Scaffold selection and scaffold hopping in lead generation: a medicinal chemistry perspective. Drug Discov. Today 2007, 12, 149-55.
59. Mauser, H.; Stahl, M. Chemical Fragment Spaces for de novo Design. J. Chem. Inf. Model. 2007, 47, 318-24.
60. Lewell, X. Q.; Judd, D. B.; Watson, S. P.; Hann, M. M. RECAP retrosynthetic combinatorial analysis procedure: a powerful new technique for identifying privileged molecular fragments with useful applications in combinatorial chemistry. J. Chem. Inf. Model. 1998, 38, 511-22.
61. WDI. World Drug Index. http://scientific.thomson.com/products/wdi/.
62. BioSolveIT. BioSolveIT GmbH. http://www.biosolyeit.de/.
63. SciTegic. SciTegic Inc., http://www.scitegic.com/.
64. Zee-Cheng, K. Y.; Pauli, K. D.; Cheng, C. C. Experimental antileukemic agents. Coralyne, analogs, and related compounds. J. Med. Chem. 1974, 17, 347-51.
65. Uckun, F. M.; Liu, X.-p.; Narla, R. K. Preparation of quinazolines as antitumor agents. WO 2000056720, 2000; Parker Hughes Institute. St. Paul, MN.
66. Yiv, S.; Li, M.; Uckun, F. M. Preparation of quinazolines for micellar pharmaceuticals for treatment of allergy and cancer. WO 2000056338. 2000; Parker Hughes Institute, St. Paul, MN.
67. Gebhardt, K.; Schimana, J.; Krastel, P.; Dettner, K.; Rheinheimer, J.; Zeeck, A.; Fiedler, H. P. Endophcnazines A - D, new phenazine antibiotics from the arthropod associated endosymbiont Streptomyces anulatus. l. Taxonomy, fermentation, isolation and biological activities. J. Antibiot. 2002, 55, 794-800.
68. Krastel, P.; Zeeck, A.; Gebhardt, K.; Fiedler, H. P.; Rheinheimer, J. Endophcnazincs A-D, new phenazine antibiotics from the athropod associated endosymbiont Streptomyces anulatus II. Structure elucidation. J. Antibiot. 2002, 55, 801-6.
69. Lindquist, C.; Ersoy, O.; Somfai, P. Parallel synthesis of an indole-based library via an iterative Mannich reaction sequence. Tetrahedron 2006, 62, 3439-3445.
70. Robinson, B. Alkaloids of Physostigma Venenosum. Iv. The Synthesis of Eseramine. J. Chem. Soc. 1965, 33, 3336-9.
71. Yu, Q. S.; Atack, J. R.; Rapoport, S. I.; Brossi, A. Synthesis and anticholinesterase activity of (-)-Nl-norphysostigmine. (-)-eseramine, and other N(l)-substituted analogues of (-)-physnstigmine. J. Med. Chem. 1988, 31, 2297-300.
72. Mattson, R. J.; Catt, J. D.; Keavy, D.; Sloan, C. P.; Epperson, J.; Gao, Q.; Hodges, D. B.; Iben, L.; Mahle, C. D.; Ryan, E.; Yocea, F. D. Indanyl piperazines as melatonergic MT2 selective agents. Bioorg. Med. Chem. Lett. 2003, 13, 1199-1202.
73. Julia, M.; Melamed, R.; Gombert, R. Research in the indole series. XVI. 2-Aryltryptamines and homologous amines. Ann. Inst. Pasteur 1965, 109, 343-62.
74. Ganellin, C. R.; Hollyman, D. R.; Ridley, H. F. Aminoalkylation of metal derivatives of indole. II. Coupling of indolylmagnesium iodides with haloalkylamines. J. Chem. Soc. C 1967, 2220-5.
75. Waletzky, E.; Berkelhammer, G.; Kantor, S. Quinazolinones for treating coccidiosis. US 3320124, 1967; American Cyanamid Co.
76. Sekera, A.; Hruby, J.; Vrba, C.; Lebduska, J. Anesthetics of carbamic acid series. Chem. Listy Vedn Prum. 1950, 44, 275-6.
77. Robitscher, J. B.; Pulver, S. E. Orphenadrine in the treatment of depression: a preliminary study. Am. J. Psychiatry 1958, 114, 1113-5.
78. Amitai, G.; Herz, J. M.; Bruckstein, R.; Luz-Chapman, S. The musearinic antagonists aprophen and benactyzine are noncompetitive inhibitors of the nicotinic acetylcholine receptor. Mol. Pharmacol. 1987, 32, 678-85.
79. Tumiatti, V.; Recanatini, M.; Minarini, A.; Melchiorre, C.; Chiarini, A.; Budriesi, R.; Bolognesi, M. L. Affinity and selectivity at M2 and M3 muscarinic receptor subtypes of cyclic and open oxygenated analogs of 4-DAMP. Farmaco 1992, 47, 1133-47.
80. Tumiatti, V.; Spampinato, S.; Recanatini, M.; Minarini, A.; Melchiorre, C.; Chiarini, A.; Budriesi, R. Design, synthesis and biological activity of some 4-DAMP-related compounds. 3. Bioorg. Med. Chem. Lett. 1995, 5, 2325-30.
81. Ruschig, H.; Korger, G.; Aumuller, W.; Wagner, H.; Weyer, R.; Bander, A.; Scholz, J. New orally effective blood sugar reducing compounds. Arzneim.-Forsch. 1958, 8, 448-54.
82. Barrass, B. C.; Elmore, D. T. Formation of cyclic lactams from derivatives of basic amino acids. J. Chem. Soc. 1957, 4830-4.
83. N-Aeylsulfonamides. GB 902881, 1962; Merck & Co., Inc.
84. Baumann, T.; Baechle, M.; Braese, S. Sulfamidation of 2-Arylaldehydcs and Ketones with Chloramine-T. Org. Lett. 2006, 8, 3797-3800.
85. Clayton, D. W.; Farrington, J. A.; Kenner, G. W.; Turner, J. M. Peptides. VI. Further studies of the synthesis of peptides through anhydrides of sulfuric acid. J. Chem. Soc. 1957, 1398-407.
86. Prous. Prous Integrity, Drugs & Biologies, http://intcgrity.prous. com/.
87. Tropisetron. Drug Data Rep. 1992, 14, 863.
88. Granisetron. Drug Data Rep. 1990, 12, 519.
89. Drug Data Rep. 1989, 11, 530.
90. Drug Data Rep. 1989, 11, 896.
91. Drug Data Rep. 1991, 13, 469.
92. Orjales, A.; Alonso-Cires, L.; Lopez-Tudanea, P.; Tapia, I.; Mosquera, R.; Labeaga, L. Benzimidazole-2-carboxylic acid amides and esters: A new structural class of 5-HT3 ligands. Eur. J. Med. Chem. 1999, 34, 415.
93. Drug Data Rep. 1992, 14, 864.
94. Drug Data Rep. 1992, 14, 54.
95. Drug Data Rep. 1988, 10, 442.
96. Xue, L.; Godden, J. W.; Bajorath, J. Database Searching for Compounds with Similar Biological Activity Using Short Binary Bit String Representations of Molecules. J. Chem. Inf. Comput. Sci. 1999, 39, 881-886.
97. Xue, L.; Stahura, F. L.; Godden, J. W.; Bajorath, J. Mini-fingerprints Detect Similar Activity of Receptor Ligands Previously Recognized Only by Three-Dimensional Pharmacophore-Based Methods. J. Chem. Inf. Comput. Sci. 2001, 41, 394-401.
98. Weininger, D.; Weininger, A.; Weininger, J. L. SMILES. 2. Algorithm for Generation of Unique SMILES Notation. J. Chem. Inf. Model. 1989, 29, 97-101.
99. Leach, A. R.; Bradshaw, J.; Green, D. V.; Hann, M. M.; Delany, J. J. 3rd. Implementation of a system for reagent selection and library enumeration, profiling, and design. J. Chem. Inf. Model. 1999, 39, 1161-72.
100. Gasteiger, J.; Rudolph, C.; Sadowski, J. Automatic Generation of 3D-Atomic Coordinates for Organic Molecules. Tetrahedron Comput. Method. 1992, 3, 537-547.
101. MolNet. Molecular Networks GmbH. http://www.mol-net.de/.
102. Ihlenfeldt, W. D.; Gasteiger, J. Hash codes for the identification and classification of molecular structure elements. J. Comput. Chem. 1994, 15, 793-813.
103. Degen, J.; Rarey, M. FlexNovo: structure-based searching in large fragment spaces. ChemMedChem 2006, 1, 854-68.